Charles F. Wagner Jr., EVP & Chief Financial Officer at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 3,250 shares at $460.00 ($1.5M) on 2024-06-03, disclosed to the SEC on 2024-06-05.
Scheduled sale ($1.5M) by EVP & Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| VRTX | SELL | 2025-03-12 | $1.6M | — | Filing → |
| VRTX | SELL | 2024-11-13 | $1.6M | — | Filing → |
| VRTX | SELL | 2024-05-30 | $3.0M | — | Filing → |